NS35 and not vp7 is the soluble rotavirus protein which binds to target cells.
Recent studies using radiolabeled rotavirus lysates have demonstrated a 35-kilodalton viral protein that binds specifically to the surface of MA104 cells (N. Fukuhara, O. Yoshie, S. Kitakoa, and T. Konno, J. Virol. 62:2209-2218, 1988; M. Sabara, J. Gilchrist, G.R. Hudson, and L.A. Babiuk, J. Virol. 53:58-66, 1985). The binding protein was identified as vp7, an outer capsid glycoprotein and the product of rotavirus gene 9. These studies concluded that vp7 mediated viral attachment to MA104 cells and that the binding of a soluble viral protein to a cell monolayer mirrored the attachment of infectious rotavirus to permissive tissue culture cells. In the process of determining which viral protein adheres to the in vivo target cell in rotavirus infection, the mammalian enterocyte, we found that a similar 35-kilodalton rhesus rotavirus (RRV) protein bound to both MA104 cells and murine enterocytes. However, further analysis of this protein by immunoprecipitation, inhibition of glycosylation, and partial proteolysis showed that it was not the RRV gene 9 product, vp7, but the gene 8 product, NS35. Similar results were obtained by using porcine rotavirus (OSU) and bovine rotavirus (NCDV) strains. Binding studies using the in vitro-expressed products of RRV genes 8 and 9 confirmed these results. Since double-shelled virions inhibited the binding of NS35 to cells, we looked for the presence of this protein in preparations of purified virus. Examination of density gradient-purified virus preparations revealed biochemical and immunological evidence that NS35 copurifies in small amounts with double-shelled virions. Thus, these studies clearly demonstrated that when rotavirus proteins are prepared in a soluble form from infected cells, NS35, and not vp7, binds to the surfaces of MA104 cells and murine enterocytes. The observations do not confirm previous experimental results which supported the hypothesis that vp7 was the viral attachment protein. They are consistent with but do not prove the hypothesis that NS35 functions as the rotavirus attachment protein.
Bass
D M
DM
Department of Medicine, Stanford University School of Medicine, California.
Mackow
E R
ER
Greenberg
H B
HB
D000327:Adsorption; D000818:Animals; D000956:Antigens, Viral; D002213:Capsid / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D036022:Capsid Proteins; D002460:Cell Line; D002478:Cells, Cultured; D004848:Epithelium / Q000382:microbiology; D005814:Genes, Viral; D007421:Intestine, Small / Q000382:microbiology; D051379:Mice; D011991:Receptors, Virus / Q000378:metabolism*; D012401:Rotavirus / Q000235:genetics / Q000502:physiology*; D014415:Tunicamycin / Q000494:pharmacology; D014758:Viral Core Proteins / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins / Q000302:isolation & purification; D015678:Viral Structural Proteins / Q000235:genetics
D000956:Antigens, Viral; D036022:Capsid Proteins; D011991:Receptors, Virus; C050779:VP7 protein, Rotavirus; D014758:Viral Core Proteins; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins; D015678:Viral Structural Proteins; D014415:Tunicamycin